Soleno Therapeutics, Inc. (SLNO) — AI Analysis & Mentions

Soleno Therapeutics has recently come under the microscope following an investigation into potential violations related to federal securities laws. While the current sentiment is neutral, investors should tread carefully, as increased scrutiny could affect the stock's volatility and thus presents an opportunity for those waiting for a dip.